title: Cassia cinnamon for the attenuation of glucose intolerance and insulin resistance resulting from sleep loss.
abstract: Epidemiological investigations reveal a concomitant increase in sleep loss and metabolic diseases, including type 2 diabetes mellitus, over the past several decades. An increasing body of scientific evidence indicates that acute sleep loss induces insulin resistance and glucose intolerance profiles similar to those of type 2 diabetes mellitus patients. Experimentally, cassia cinnamon (Cinnamomum cassia) supplementation facilitates glucose disposal in healthy humans, which may be achieved by enhancing (1) insulin sensitivity via increased phosphorylation of signaling proteins and (2) insulin-sensitive glucose transporter 4-mediated glucose uptake into muscle cells. Because peripheral insulin resistance is primarily a consequence of reduced muscle insulin sensitivity, C. cassia and C. cassia extracts may attenuate insulin resistance and glucose intolerance observed following sleep loss.
authors.affiliation: Department of Health, Human Performance, Recreation, Baylor University, Waco, Texas 76798-7313, USA. Jean_Jitomir@baylor.edu
authors.forename: Jean
authors.initials: J
authors.lastname: Jitomir
authors.forename: Darryn S
authors.initials: DS
authors.lastname: Willoughby
mesh_terms: D002935:Cinnamomum zeylanicum; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control*; D019587:Dietary Supplements; D018149:Glucose Intolerance / Q000188:drug therapy* / Q000209:etiology; D051275:Glucose Transporter Type 4 / Q000378:metabolism; D006801:Humans; D007333:Insulin Resistance; D008517:Phytotherapy; D028321:Plant Preparations / Q000627:therapeutic use*; D015398:Signal Transduction / Q000187:drug effects; D012892:Sleep Deprivation / Q000150:complications*
chemical_list: D051275:Glucose Transporter Type 4; D028321:Plant Preparations